Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00239694 · ClinicalTrials.gov registry record · Phase 4

PPV: Pneumococcal Polysaccharide Vaccine in Older Adults

A Phase 4 study, sponsored by National Institute on Aging (NIA).

Completed
Registry status
Phase 4
Development phase
100
Enrollment target

NCT00239694: Completed Phase 4 study, sponsored by National Institute on Aging (NIA).

NCT00239694 is a Phase 4 study that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00239694, a Phase 4 study, has completed, sponsored by National Institute on Aging (NIA).

COMPLETED
Registry status
Phase 4
Development phase
100 participants
Enrollment target

Study Summary

The purpose of this study is to measure how long the improvement in the immune system lasts in older people after they have been vaccinated, and to examine the immune response in older people who get vaccinated a second time.

Interventions

  • BIOLOGICAL Pneumococcal Vaccine
  • BIOLOGICAL Meningococcal Vaccine

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2001-04
Est. Completion 2012-08
Phase Phase 4
National Institute on Aging (NIA)

131 total trials

What the finished NCT00239694 record still lists

NCT00239694 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 2 interventions - of which Pneumococcal Vaccine is the first listed.

NCT00239694 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00239694 about?

NCT00239694 is a clinical study titled "PPV: Pneumococcal Polysaccharide Vaccine in Older Adults". The purpose of this study is to measure how long the improvement in the immune system lasts in older people after they have been vaccinated, and to examine the immune response in older people who get vaccinated a second time.

What is the current status of trial NCT00239694?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2001-04. Estimated completion is 2012-08.

What interventions are being tested in trial NCT00239694?

The interventions under investigation include: Pneumococcal Vaccine (BIOLOGICAL), Meningococcal Vaccine (BIOLOGICAL).

Who is sponsoring clinical trial NCT00239694?

This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00239694's enrollment target sits among peer trials

100 770th of 2000 higher than 1,148 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00239694, the US trial registry maintained by the National Library of Medicine. NCT00239694 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.